Sage Therapeutics Inc.

In News

Former Sage Therapeutics executives launch neurology biotech with $106M - The Business Journals

The Business Journals - Apr 21, 2026

SAGE Therapeutics stock holds near recent levels as Nasdaq rises - AD HOC NEWS

AD HOC NEWS - Sep 23, 2026

Supernus Pharmaceuticals to Acquire Sage Therapeutics, Strengthening its Neuropsychiatry Product Portfolio - GlobeNewswire

GlobeNewswire - Jun 16, 2025

Sage Therapeutics, Inc. (SAGE) Bought by Supernus to Boost Neuropsychiatric Portfolio - Yahoo Finance

Yahoo Finance - Sep 02, 2025

Sage Therapeutics Confirms Receipt of Unsolicited Nonbinding Acquisition Proposal from Biogen - Business Wire

Business Wire - Jan 10, 2025

Jon F. Elevated to Associate Vice President of Business Development at Axsome Therapeutics, Inc. - https://hrtoday.in/

https://hrtoday.in/ - Apr 06, 2026

Sage Therapeutics and Biogen Announce Topline Results from Phase 2 KINETIC 2 Study of SAGE-324 (BIIB124) for the Treatment of Essential Tremor - Biogen

Biogen - Jul 24, 2024

Sage, following setbacks, to sell to Supernus for $561M - BioPharma Dive

BioPharma Dive - Jun 16, 2025

Sage lays off entire staff of 338 amid takeover by Supernus - Fierce Pharma

Fierce Pharma - Jun 30, 2025

Sage Therapeutics' CFO to leave, drugmaker to lay off over 165 employees - Reuters

Reuters - Oct 17, 2024

Sage’s Story Comes to ‘Good End’ With Up To $795M Acquisition by Supernus - BioSpace

BioSpace - Jun 16, 2025

Supernus Pharmaceuticals Completes Acquisition of Sage Therapeutics - GlobeNewswire

GlobeNewswire - Jul 31, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment